Ovarian Cancer
World Ovarian Cancer Day: Education and Advances in Treatment
For World Ovarian Cancer Day, Eirwen M. Miller, MD, discussed the current state of ovarian cancer treatment, new developments in the space, and unmet needs.
Read More
Advancing the Treatment of Cervical and Endometrial Cancers
In season 2, episode 6 of Targeted Talks, Alexander B. Olawaiye, MD leads a discussion with Haider S. Mahdi, MD, about the modern approaches to treating cervical and endometrial cancers.
Listen
Improving Identification Within Asian American Subgroups With Ovarian Cancer
Sarah Lee, MD, MBA, discussed a study to better disaggregate the subgroup of Asian American patients with ovarian cancer.
Precision Medicine Guiding Ovarian Cancer Treatment
Sarah M. Temkin, MD leads discussion with Daphne B. Stewart, MD, around targeted therapies in ovarian cancer, whether offered in the academic or community setting.
FDA Clears IND of BAT8006 in Platinum-Resistant Ovarian Cancers
A phase 2 trial plans to evaluate BAT8006 for the treatment of patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
McHale Analyzes the Benefits and Challenges of PARP Inhibition for Certain Patients With Advanced Ovarian Cancer
At a live virtual event, Michael McHale, MD, led a roundtable discussion on the use of PARP inhibition therapy for patients with advanced ovarian cancer.